JP2001502534A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001502534A5 JP2001502534A5 JP1998517538A JP51753898A JP2001502534A5 JP 2001502534 A5 JP2001502534 A5 JP 2001502534A5 JP 1998517538 A JP1998517538 A JP 1998517538A JP 51753898 A JP51753898 A JP 51753898A JP 2001502534 A5 JP2001502534 A5 JP 2001502534A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/710,305 | 1996-09-17 | ||
| US08/710,305 US5801012A (en) | 1996-09-17 | 1996-09-17 | Methods and compositions for generating angiostatin |
| PCT/US1997/016539 WO1998015574A1 (en) | 1996-09-17 | 1997-09-17 | Methods and compositions for generating angiostatin |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2001502534A JP2001502534A (ja) | 2001-02-27 |
| JP2001502534A5 true JP2001502534A5 (enExample) | 2005-05-12 |
| JP4160121B2 JP4160121B2 (ja) | 2008-10-01 |
Family
ID=24853480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51753898A Expired - Fee Related JP4160121B2 (ja) | 1996-09-17 | 1997-09-17 | アンジオスタチン生成のための方法及び組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US5801012A (enExample) |
| EP (2) | EP1705184A1 (enExample) |
| JP (1) | JP4160121B2 (enExample) |
| AT (1) | ATE329926T1 (enExample) |
| AU (1) | AU4422797A (enExample) |
| CA (1) | CA2265550A1 (enExample) |
| DE (1) | DE69736129T2 (enExample) |
| ES (1) | ES2267151T3 (enExample) |
| WO (1) | WO1998015574A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5945403A (en) * | 1997-05-30 | 1999-08-31 | The Children's Medical Center Corporation | Angiostatin fragments and method of use |
| US7297331B2 (en) * | 1996-04-03 | 2007-11-20 | The Rogosin Institute | Beads containing restricted cancer cells producing material suppressing cancer cell proliferation |
| WO1999000420A1 (en) * | 1997-06-26 | 1999-01-07 | Karolinska Innovations Ab | Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
| JP2002531385A (ja) * | 1998-11-25 | 2002-09-24 | ブリストル−マイヤーズ スクイブ カンパニー | アンジオスタチンおよびプラスミノゲンのクリングル５領域を含む組成物およびその使用方法 |
| EP1214346A1 (en) | 1999-09-15 | 2002-06-19 | Mogam Biotechnology Research Institute | A novel angiogenesis inhibitor |
| AU2001234926A1 (en) * | 2000-02-08 | 2001-08-20 | Northwestern University | Methods and compositions for generating angiostatin |
| CA2421251A1 (en) | 2000-09-05 | 2002-03-14 | Karolinska Innovations Ab | Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen |
| US7420036B2 (en) | 2000-11-28 | 2008-09-02 | Waisman David M | Anti-angiogenic polypeptides |
| ITMI20011995A1 (it) * | 2001-09-26 | 2003-03-26 | Ist Naz Ricerca Sul Cancro | Sostanze ad attivita' antinfiammatoria |
| US7285277B2 (en) * | 2002-03-15 | 2007-10-23 | Mogam Biotechnology Research Institute | Anticancer agent |
| CN100384819C (zh) * | 2002-07-02 | 2008-04-30 | 诺瓦提斯公司 | 与细胞凋亡蛋白抑制剂结合的smac蛋白的肽抑制剂 |
| AU2003297181A1 (en) * | 2002-12-13 | 2004-07-09 | Mediomics, Llc | Compositions and methods for inhibiting tumor growth and metastasis |
| US7141035B2 (en) * | 2003-03-28 | 2006-11-28 | Sherwood Services Ag | Catheter with occlusion resistant tip |
| US7090654B2 (en) * | 2003-03-28 | 2006-08-15 | Sherwood Services Ag | Catheter with occlusion resistant tip |
| US7776005B2 (en) * | 2003-03-28 | 2010-08-17 | Covidien Ag | Triple lumen catheter with occlusion resistant tip |
| US20050281879A1 (en) * | 2003-11-14 | 2005-12-22 | Guohua Chen | Excipients in drug delivery vehicles |
| CN1889929B (zh) * | 2003-11-14 | 2013-04-10 | 阿尔萨公司 | 药物递送媒介物中的赋形剂 |
| CN101107023B (zh) | 2004-11-04 | 2010-06-09 | 科维蒂恩股份公司 | 导管插入装置 |
| US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
| WO2009100617A1 (zh) * | 2008-02-04 | 2009-08-20 | Shanghai First People's Hospital | 抑制血管新生的多肽及其应用 |
| EP2445547B1 (en) * | 2009-06-26 | 2017-08-02 | Covidien LP | Catheterization system |
| CA2715857A1 (en) | 2009-09-30 | 2011-03-30 | Tyco Healthcare Group Lp | Medical catheter having a design providing low recirculation and reversibility |
| US8747343B2 (en) | 2011-09-30 | 2014-06-10 | Covidien Lp | Hemodialysis catheter with improved side opening design |
| US9072867B2 (en) | 2011-09-30 | 2015-07-07 | Covidien Lp | Catheter with external flow channel |
| US9216163B2 (en) | 2013-05-20 | 2015-12-22 | Kyorin Pharmaceutical Co., Ltd. | Method of inhibiting angiogenesis |
| KR20220140711A (ko) | 2020-01-13 | 2022-10-18 | 듀렉트 코퍼레이션 | 불순물이 감소된 지속 방출 약물 전달 시스템 및 관련 방법 |
| EP4277702A1 (en) | 2021-01-12 | 2023-11-22 | Durect Corporation | Sustained release drug delivery systems and related methods |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2431342C3 (de) * | 1973-07-27 | 1978-10-26 | Behringwerke Ag, 3550 Marburg | Verfahren zur Messung des Plasminogengehaltes durch Bestimmung der Bildung von Fibrin in einer Probe |
| US4968494A (en) * | 1987-03-27 | 1990-11-06 | Merck & Co., Inc. | Methods and compositions for thrombolytic therapy |
| US5135919A (en) | 1988-01-19 | 1992-08-04 | Children's Medical Center Corporation | Method and a pharmaceutical composition for the inhibition of angiogenesis |
| US5021404A (en) | 1988-04-20 | 1991-06-04 | The Children's Medical Center Corporation | Angiostatic collagen modulators |
| KR0138530B1 (ko) | 1988-09-01 | 1998-05-15 | 우메모또 요시마사 | 푸마길롤 유도체 |
| PT93847A (pt) | 1989-04-24 | 1990-11-20 | Harvard College | Processo para a preparacao de oligossacaridos de baixo peso molecular derivados de heparina ou de sulfato de heparano despolimerizados e de composicoes farmaceuticas que os contem |
| US5290807A (en) | 1989-08-10 | 1994-03-01 | Children's Medical Center Corporation | Method for regressing angiogenesis using o-substituted fumagillol derivatives |
| US5192744A (en) | 1990-01-12 | 1993-03-09 | Northwestern University | Method of inhibiting angiogenesis of tumors |
| US5504074A (en) | 1993-08-06 | 1996-04-02 | Children's Medical Center Corporation | Estrogenic compounds as anti-angiogenic agents |
| WO1995029242A1 (en) * | 1994-04-26 | 1995-11-02 | The Children's Medical Center Corporation | Angiostatin and method of use for inhibition of angiogenesis |
| US5639725A (en) | 1994-04-26 | 1997-06-17 | Children's Hospital Medical Center Corp. | Angiostatin protein |
| US5837682A (en) | 1996-03-08 | 1998-11-17 | The Children's Medical Center Corporation | Angiostatin fragments and method of use |
| US5945403A (en) | 1997-05-30 | 1999-08-31 | The Children's Medical Center Corporation | Angiostatin fragments and method of use |
| US5861372A (en) | 1996-02-22 | 1999-01-19 | The Children's Medical Center Corporation | Aggregate angiostatin and method of use |
| MX9708217A (es) | 1995-04-26 | 1997-12-31 | Childrens Medical Center | Fragmentos de angiostatina y angiostatina agregada y metodos de uso. |
| AU6264596A (en) | 1995-06-07 | 1996-12-30 | Children's Medical Center Corporation | Diagnosis, prognosis and monitoring of angiogenesis dependen t diseases |
| DE19529223A1 (de) * | 1995-08-09 | 1997-02-13 | Boehringer Mannheim Gmbh | Verwendung von Plasminogenaktivatoren zum lokalen Knochenaufbau |
| ES2206602T3 (es) | 1995-10-23 | 2004-05-16 | The Children's Medical Center Corporation | Compuestos y metodos terapeuticos inhibidores de angiogenesis. |
| US5854221A (en) | 1996-12-12 | 1998-12-29 | The Children's Medical Center Corporation | Endothelial cell proliferation inhibitor and method of use |
| WO1997023500A1 (en) | 1995-12-13 | 1997-07-03 | The Children's Medical Center Corporation | Endothelial cell proliferation inhibitor and method of use |
| HU224827B1 (hu) | 1996-05-03 | 2006-02-28 | Abbott Lab | Új antiangiogén peptidek, azokat kódoló polinukleotidok, és eljárások angiogenezis gátlására |
| WO1999000420A1 (en) | 1997-06-26 | 1999-01-07 | Karolinska Innovations Ab | Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
-
1996
- 1996-09-17 US US08/710,305 patent/US5801012A/en not_active Expired - Fee Related
-
1997
- 1997-09-17 EP EP06112574A patent/EP1705184A1/en not_active Withdrawn
- 1997-09-17 DE DE69736129T patent/DE69736129T2/de not_active Expired - Fee Related
- 1997-09-17 CA CA002265550A patent/CA2265550A1/en not_active Abandoned
- 1997-09-17 JP JP51753898A patent/JP4160121B2/ja not_active Expired - Fee Related
- 1997-09-17 AT AT97942549T patent/ATE329926T1/de not_active IP Right Cessation
- 1997-09-17 EP EP97942549A patent/EP0964869B1/en not_active Expired - Lifetime
- 1997-09-17 WO PCT/US1997/016539 patent/WO1998015574A1/en not_active Ceased
- 1997-09-17 ES ES97942549T patent/ES2267151T3/es not_active Expired - Lifetime
- 1997-09-18 AU AU44227/97A patent/AU4422797A/en not_active Abandoned
- 1997-12-16 US US08/991,761 patent/US6576609B1/en not_active Expired - Fee Related